← Journal search
JOURNAL PROFILE
Download details (PDF) ↓

Blood Advances (ISSN 2473-9529, 2473-9537) is an open-access journal published by American Society of Hematology in the United States. It covers Medicine and Hematology. It is indexed in Scopus, Web of Science, PubMed, DOAJ and HEC. Recorded metrics: impact factor 7.7, Scopus Q1, Web of Science Q1, CiteScore 11.8 and HEC W-Category. Article processing charge: USD 4,000. This profile brings together the journal's ISSN, publisher, country, subject area, HEC category, Scopus data, SJR and SCImago rank, Web of Science data, impact factor, indexing, open access status, APC, waiver policy, time to publication, aims and scope, about the journal, author instructions, journal website and registration details from the most reputable indexes, in one place.

Journal title

Blood Advances

ISSN
2473-9529, 2473-9537
Subject area
MedicineHematology
Indexed
ScopusWeb of SciencePubMedDOAJHEC
Scopus Quartile
Q1
WoS Quartile
Q1
Impact Factor
7.7
Country
United States
Publisher
American Society of Hematology
SJR
3.11
Open access
Yes
APC (USD)
4000
About the journal
Blood Advances is a fully open-access journal published by Elsevier (United States). It has published all content under an open licence (CC BY-NC-ND) since 2016. Topics: medicine, internal medicine, hematology, diseases of the blood and blood-forming organs, hematologic oncology, vascular biology.
Aims and Scope
Blood Advances publishes original basic laboratory, translational, and clinical research in hematology and related sciences. Its coverage spans areas including clinical trials, gene therapy, hematopoiesis and stem cells, immunobiology, blood cancers, red-cell and platelet biology, thrombosis and hemostasis, transfusion, transplantation, and vascular biology. The journal also publishes formats such as case reports and point-counterpoint discussions, and welcomes work on health services and outcomes.
Journal Website
Journal Website Direct Link ↗
Instructions for Authors URL
Journal's Author Direct Link ↗
Scopus URL
Scopus Direct Link ↗
APC Information URL
APC Information Direct Link ↗
WoS URL
Web of Science Direct Link ↗
SCImago Ranking
677
HEC
W-Category
Registered In
2016
Average Time To Publication After Submission (In Weeks)
16
Waiver policy
Yes
Scopus Cite Score
11.8
WoS Status
Science Citation Index Expanded (SCIE)

Record last updated . Check current status at HEC HJRS, Scopus and the Web of Science Master Journal List before submitting. About our data.

Quick answers about Blood Advances

Is Blood Advances HEC recognised?

Yes. The catalogue records Blood Advances in HEC category W of the HEC Journal Recognition System, where W is the highest and Y the lowest category. Confirm the current category on HEC's HJRS website before you submit.

Is Blood Advances indexed in Scopus?

Yes. Blood Advances is listed as Scopus-indexed, in quartile Q1, with a CiteScore of 11.8. Check its current status on the Scopus Sources page.

Is Blood Advances in Web of Science?

Yes. Blood Advances is listed as a Web of Science journal in the Science Citation Index Expanded (SCIE), with Web of Science quartile Q1. Confirm on Clarivate's Master Journal List.

What is the impact factor of Blood Advances?

The recorded journal impact factor of Blood Advances is 7.7. Clarivate updates impact factors every year in Journal Citation Reports.

Is Blood Advances open access, and what does it charge?

Blood Advances is an open-access journal and its APC is USD 4,000. Fees change, so check the journal's website before you submit.

How long does Blood Advances take to publish?

The recorded average time from submission to publication is about 16 weeks. Individual papers can take longer, especially when revisions are requested.

Who publishes Blood Advances?

Blood Advances is published by American Society of Hematology in United States, under ISSN 2473-9529 and 2473-9537.

Research profile

Main research topics: Lymphoma Diagnosis and Treatment, Acute Myeloid Leukemia Research, Hematopoietic Stem Cell Transplantation, Chronic Lymphocytic Leukemia Research, Platelet Disorders and Treatments, Acute Lymphoblastic Leukemia research.

Source: OpenAlex (CC0), retrieved 21 November 2026. Counts cover works OpenAlex has indexed and differ from Scopus and Web of Science.

Browse similar journals

Find Journal